Home » Newsletters » BioWorld Science

BioWorld Science

June 23, 2017

View Archived Issues

Moleculin Biotech reports discovery of follow-on to WP-1122

Takeda initiates phase II study of TAK-935 in developmental or epileptic encephalopathies

FDA's ODAC to evaluate Zepsyre's potential for pediatric cancers

ISU Abxis is enrolling patients in phase I trial of ISU-304

UCB details development of PI3Kdelta inhibitor seletalisib

Patient recruitment begins in phase I trial of LXI-15029 in patients with advanced solid tumors

Phase I data presented for M-3814 in patients with solid tumors

Reata Pharmaceuticals granted FDA orphan drug designation for omaveloxolone

Angion Biomedica enters license agreement with ElexoPharm

Zogenix 's ZX-008 wins FDA orphan drug designation

PharmNovo prepares delta opioid receptor agonist PN-6047 for clinical investigation

Kamada withdraws MAA for inhaled AAT therapy

Zealand Pharma and Beta Bionics report phase IIa data on dasiglucagon with artificial pancreas

U.K.'s MHRA gives positive opinion to idebenone through EAMS for DMD

Pirotinib tested in phase I study in advanced solid tumor patients

Amgen develops PET probe for cytotoxic lymphocyte detection for cancer immunotherapy

DelMar Pharmaceuticals cleared to conduct phase III study of VAL-083 in GBM

Ewopharma acquires rights to several Eisai products

Merck & Co. divulges coagulation factor XIa/kallikrein B inhibitors

AstraZeneca/Cancer Research Technology patent GLS inhibitors

FDA approves subcutaneous Haegarda to prevent HAE attacks

GlaxoSmithKline presents novel UDP-3-O-acyl-GlcNAc deacetylase inhibitors

Sarepta Therapeutics and Genethon sign gene therapy research collaboration for DMD

FDA issues complete response letter for Trintellix

FDA grants orphan drug designation to IMO-2125 for melanoma

SM-04690 shows promise in phase II trial for knee osteoarthritis

FDA approves Tafinlar + Mekinist for BRAF V600E-positive NSCLC

CPI-444 demonstrates clinical activity in patients with NSCLC and RCC

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...